News & Press Releases

TORONTO – Mintz continues to grow in Canada and extend its market-leading life sciences and private equity capabilities. The addition of Partners Matthew Atkey and Brad Tartick, Special Counsel Bernard Kwasniewski and Of Counsel Matthew Imrie, will bolster Mintz’s premier capital markets, M&A, funds, and employment and pensions-focused practices.

Law.com covered the arrival of Toronto Partners Matthew Atkey and Brad Tartick, Special Counsel Bernard Kwasniewski and Of Counsel Matthew Imrie.

WASHINGTON, D.C. – Mintz’s Private Equity Co-Chair, Matthew T. Simpson is one of a group of experts arranged by the Public International Law & Policy Group (PILPG) to develop a series of tools and resources to assist with potential future ceasefire negotiations between Ukraine and Russia.

Member Frank Gerratana spoke to Insider about the growing use of AI technology and how this will impact copyright laws.

NEW YORK – Mintz represented the syndicate of underwriters led by William Blair & Company, L.L.C., in the public offering of 17,242,000 shares of common stock of Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, at an initial offering price of $14.50 per share.

Chair of the Sports & Entertainment Practice Steven Olenick was a guest on Bloomberg's Business of Sports Podcast where he provided insight on the WWE-Endeavor deal.